Market Size (2016)
2016
$8.00B
Vertical: HealthcareBase Year: 201813 Sections
Market Size (2016)
2016
$8.00B
Projected (2025)
2025
$23.54B
CAGR (2016–2025)
12.7%
12.7%Key Players
109+
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Aesthetic procedures are the treatment done for the improvement of cosmetic appearance. Various aesthetic techniques are available in the market, which is effectively used for liposuction, hair removal, acne treatment, and others. Medical aesthetics are concerned with the use of various aesthetic products for medical purposes and to improve the overall appearance of the patient.
Key Contributing Factors
There are numerous factors that contribute to the growth of the global medical aesthetics market. The key factors are mentioned below in brief.
High Demand for Liposuction, Hair Transplantation, and the Rising Obese and Geriatric Population
According to the American Society for Aesthetic Plastic Surgery, 414,335 liposuction procedures were performed in the US in 2016.
Increasing Expenditure On Cosmetic and Aesthetic Procedures
According to the Cosmetic Physicians College of Australia in 2015, the Australians spent approximately USD 890 million on minimally invasive or non-invasive cosmetic procedures, exhibiting an increase of 5% as compared to 2014. Moreover, according to the International Trade Administration, in 2014, the per capita cosmetic expenditure in Japan was around USD 174.
Increasing Incidence of Skin Diseases
According to a study published in the Journal of Dermatological Case Reports in 2015, actinic keratosis is common in fair-skinned individuals when exposed to adequate sunlight. Moreover, the study reported that in Australia, approximately 40% to 50% of the Caucasian population, aged 40 years or more, develops actinic keratosis.
The Medical Aes Market market is projected to grow at a CAGR of 12.7% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMedical aesthetics refer to specialties which focus on improving cosmetic appearance by treating conditions such as wrinkles, scars, cellulite, unwanted hair, and moles, amongst others. The current trend is use of non-invasive procedures to treat cosmetic imperfections. Increasing awareness about the benefits of combination therapies in aesthetic medicines is leading to its widespread acceptance among the population of all age groups. The global medical aesthetics market has been bifurcated into product, end user, and region.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter’s five forces model gives a framework that models the global medical aesthetics market, which is influenced by five forces. The strategic business managers, trying to create an edge over competing firms in the global medical aesthetics market can utilize this model to comprehend better the industry connection in which the firm operates. The components of each of the forces and the degree or impact of each component in the context of the global medical aesthetics industry have been broken down and analyzed below.
Bargaining Power of Suppliers
The bargaining power of suppliers in the medical aesthetics market is moderate. In the global aesthetics industry, suppliers are raw materials manufacturers and Original Intermediate Equipment Manufacturers (OEM). The number of suppliers in the market is sufficiently high to provide plenty of options to the manufacturers for material sourcing which is required for the production of the various products, thus leaving suppliers with moderate bargaining power. Another factor affecting the bargaining power of suppliers is the supplier switching cost for buyers owing to the presence of a moderate number of raw material suppliers in the market. On the other hand, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market. Switching cost of these suppliers is high as the suppliers tend to enter long-term associations with the manufacturers.
Bargaining Power of Buyers
The bargaining power of buyers is low to moderate in the medical aesthetics market. Hospitals and cosmetic surgery clinics are the primary buyers in the market. The presence of buyers in the market is growing due to the increasing awareness of the benefits of aesthetic procedures, along with the rising number of various aesthetics procedures. The buyers of aesthetic products are moderately inclined towards branded products manufactured by renowned companies. Moreover, the buyers can exert moderate pressure on the manufacturers as there are many manufacturers that are present in the market. Also, some buyers are price-sensitive and might prefer less technologically advanced non-invasive procedures, thereby moderately affecting their bargaining power in the market.
Threat of New Entrants
The threat of new entrants is moderate in the global medical aesthetics market due to the development of the potential market. Any aesthetic manufacturing company trying to enter the market is required to accept and abide by the mandatory regulatory standards. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. The rising awareness regarding the aesthetic procedures and its benefits among the patients pushes the currently established and other manufacturers to focus more toward the adoption of innovative technologies. There is a stronghold of the big companies in this market, which can make the entry of the new players challenging. Thus, the threat of new entrants in the market is moderate.
Threat of Substitutes
The threat of substitutes in the global medical aesthetics market is low to moderate. Substitutes pose a low to moderate threat in the global medical aesthetics market due to the low availability of alternative therapies present in the market. However, quality and trust issue for the dermal fillers and devices provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global medical aesthetics market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the medical aesthetics market are trying to develop cost-effective products to make product differentiation more affordable. To overcome the competition, players are engaged in developing a process to lower their manufacturing cost. Moreover, the players are also developing advanced techniques for differentiating their product from their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $10.45B by 2025, while Asia Pacific is projected to grow fastest at a 13.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Europe | $2.25B | $3.98B | $6.43B | 12.4% | 24% |
| Asia Pacific | $1.56B | $2.86B | $4.72B | 13.1% | 18% |
| Middle East and Africa | $1.56B | $2.86B | $4.72B | 13.1% | 18% |
| Americas | $3.51B | $6.37B | $10.45B | 12.9% | 40% |
| Total | $8.88B | $16.07B | $26.32B | 12.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$23.54B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Facial Aesthetic | $7.12B | 12.7% | 54% |
| Body Contouring Devices | $4.68B | 12.7% | 82% |
| Cosmetic Implants | $3.62B | 12.7% | 88% |
| Hair Removal Devices | $2.80B | 12.7% | 85% |
| Skin Aesthetic Devices | $2.32B | 12.7% | 40% |
| Product_Others | $1.97B | 12.7% | 89% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Medical Aes Market covering market dynamics, competitive landscape, and strategic outlook.
The Medical Aes Market market is projected to reach $23.54B by 2025, growing at 12.7% CAGR. The Facial Aesthetic segment holds the largest share.
The global medical aesthetics market is mainly driven by the high demand for liposuction, hair transplantation, and increasing acceptance of facial aesthetics in the aesthetic industry. The growing expenditure on cosmetic surgeries coupled with technological advancements, rising obese and geriatric population, and the prevalence of skin diseases are expected to drive the market growth. High procedural costs, sophistication, and training associated with aesthetic procedures, and side-effects related to cosmetic procedures may slow down the growth of the market during the forecast period. Rising demand for minimally invasive procedures provides an opportunity for the growth of the market.
The growing obese and geriatric population across the globe is leading to an increased demand for aesthetic procedures such as liposuction, hair transplantation, and others. Moreover, the growing demand for beauty treatments and other anti-aging-related cosmetic procedures are accelerating the growth of the global medical aesthetics market. The rising need to appear younger and visible positive effects of these treatments are increasing the popularity of aesthetic procedures across the globe.
In 2016, according to the International Society of Aesthetic Plastic Surgery, an estimated 18,447 liposuction procedures were performed in Taipei, accounting for 1.3% of the total surgical liposuction procedures across the globe. Moreover, it was determined that India stood third in liposuction procedures, representing 5.0% of the total liposuction procedures performed in the world. According to the American Society for Aesthetic Plastic Surgery, 414,335 liposuction procedures were performed in the US in 2016.
According to the Australian Institute of Health and Welfare from 2014 to 2015, approximately two-thirds, i.e., 63% of the Australian population aged 18 and above were estimated to be overweight or obese, thus increasing the number of individuals with hair fall problem as obesity affects hair fall.
The number of hair restoration patients in Asia was approximately 427,709 in 2014, according to the International Society of Hair Restoration Surgery.
As per the Hair Society, around 40% hair loss rate is estimated in men by the age of 35, which is expected to grow and reach up to 70% in men by the age of 80 years.On the other hand, women of around 60 years of age have a hair loss rate of approximately 80%. Moreover, the Economic and Social Commission for Asia-Pacific estimated that in 2016, about 12.4% of the population within the region was aged 60 or more and is expected to reach 1.3 billion by 2050. This increasing obese population, in turn, is expected to increase the number of patients suffering from hair fall and hence increase the number of hair transplantation procedures.
Furthermore, there is a trend of getting tattoos among people in developing economies such as India, China, and Japan. This increases the probability of tattoo removal procedures, enhancing the growth of the medical aesthetics market in the region. With the high demand for procedures such as liposuction and hair transplantation by the growing obese and geriatric population, the global market for medical aesthetics is estimated to grow substantially during the forecast period.
The demand for minimally invasive procedures is increasing, and non-surgical procedures are being performed in hospital-based outpatient clinics. Moreover, the per capita incomes and healthcare expenditure in economies such as India is rising, which is likely to provide a significant boost to the market growth during the forecast period.
The population in developing economies is focusing on minimally invasive procedures to treat a variety of medical and aesthetic imperfections such as scars, wrinkles, skin discoloration, unwanted spots, excess fat, and spider veins.
According to the International Society of Aesthetic Plastic Surgery in 2016, approximately 43,047 and 15,764 non-surgical procedures for botulinum toxin and hair removal were performed in Australia.
The Asian-Pacific Islander population, according to the American Society of Plastic Surgeons, accounted for approximately 5.0%, in 2016, of all the reported cases of microdermabrasion.
In 2016, the International Society of Aesthetic Plastic Surgery stated that 120,640 non-surgical photo rejuvenation procedures were performed in Japan. Increasing demands for minimally invasive aesthetic procedures are providing growth opportunities, which can be attributed to the expansion of the market.
Despite the growing adoption of aesthetics, the high cost associated with the aesthetics procedure is hampering the growth of the market. The cost of breast augmentation is high. In India, the cost of breast augmentation is estimated to be around USD 1,200 to USD 2,200, depending upon the type of augmentation.
Moreover, within the region, liposuction can cost from USD 550 to USD 2,600. The average estimated cost of laser slimming treatment in Japan is estimated to be in the range of USD 2520 to USD 3025. The presence of middle and low-income countries within the Asia-Pacific and the Middle Eastern and African regions, may not support the growth of the market during the forecast period.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Medical Aes Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Syneron Medical Ltd
Syneron Medical Ltd. also known as Syneron Candela is the global player in the aesthetic medical devices and has distribution network worldwide. The company sells it’s products under three brand names Syneron, Candela and CoolTouch. The products are marketed, serviced and supported in 86 countries worldwide. The offices are present in North America, France, Germany, Italy, U.K, Australia, China, Japan and Hong Kong. The company was founded in 2000 and is headquartered in Yokneam Lllit, Israel. Company has various subsidiaries under its name. The company is recommended number 1 for the energy device brand by U.S dermatologist. The Syneron Candela is highly recognized brand for the hair removal, facial rejuvenation, skin tightening & vascular treatments.
Alma Lasers
Company Headquarters: Nuremberg, Germany Founded: 2000 Workforce: ~201-500 Company Working: Alma Lasers was acquired by Sisram Medical which represents Fosun Pharma Group. The company is actively engaged in the development, manufacturing, and distribution of laser, light-based, radiofrequency, and ultrasound products. It operates through business segments namely, medical aesthetics and surgical and mainly focuses on the manufacturing of energy-based solutions. UniPolar, SHR, ClearLift, FemiLift, and Soprano are some popular brands marketed by Alma Lasers. The company is directly present in more than 80 countries and provide its products directly or through a distribution partner.
Cutera
Company Headquarters: California, US Founded: 1998 Workforce: ~540 Company Working: Cutera is a global manufacturer and supplier of laser and energy-based aesthetic systems to practitioners all over the world. The Company creates, develops, manufactures, distributes, and markets light and energy-based product platforms for physicians and other qualified practitioners to employ to provide safe and effective cosmetic treatments to its consumers. Furthermore, the Company sells third party-made skincare items. The Company's continuous research and development activities are primarily focused on the creation of new products as well as the improvement and enhancement of the Company's existing product line.
Hologic Inc.
Company Headquarters: US Founded: 1985 Workforce: 6,705 Company Working: Hologic Inc. is a medical technology company based in Marlborough, Massachusetts, USA. The company specializes in developing and manufacturing diagnostic and surgical products for women's health, including mammography and biopsy systems, cervical cancer screening tests, and other medical devices. Hologic is known for its advanced technologies and innovative solutions that help healthcare providers detect and treat various diseases. Hologic's biopsy device is also known for its patient-friendly features, such as a smaller incision size and reduced pain and discomfort during the procedure. The device is widely used by healthcare providers in both hospitals and outpatient settings, helping to improve patient outcomes and reduce the need for more invasive procedures. Hologic has a significant global presence, with operations in over 50 countries around the world. The company's products are sold in more than 90 countries, and it has manufacturing facilities and research and development centers in multiple locations.
Lumenis
Company Headquarters: Yokneam, Israel Founded: 1991 Workforce: ~1137 Company Working: Lumenis develops and commercializes medical systems for use in minimally invasive procedures worldwide. It was formerly known as ESC Medical Systems Ltd and changed its name to Lumenis in September 2001. It operates through three segments, namely surgical, ophthalmic, and aesthetic. The aesthetics segment offers products related to hair removal, body, skin treatment, pigmentation, scar treatment, and tattoo removal. Moreover, the company markets its products through a network of third-party distributors, direct sales force, and independent distributors.
Anika Therapeutics Inc.
Company Headquarters: Massachusetts, US Founded: 1992 Workforce: ~133 Company Working: Anika Therapeutics is an orthopedic and regenerative medicines company. Its offers products based on hyaluronic acid, biocompatible polymer, and natural chemical. In the US, the company owns 19 patents and internationally 187 patents. In 2018, the company’s top five customers account 86% of the revenue, e.g., Mitek, a part of Johnson & Johnson medical device company and the global leader in orthopedic sports medicine accounted 73% of the company sales revenue. The company primarily depends on a small number of large customers, particularly Mitek, for the majority of its sales revenues. The company markets and distribute its products in the US, Italy, and European countries, among others.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Medical Aes Market